Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 10.5B | 12.5B | 15.1B | 14.0B |
Cost of revenue | 3.3B | 4.3B | 4.7B | 4.4B |
Gross profit | 7.2B | 8.2B | 10.4B | 9.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.8B | 3.3B | 3.7B | 4.9B |
Operating income | 3.1B | 4.6B | 6.4B | 4.5B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 803.0M | 835.2M | 754.1M | 555.7M |
Other income expense | — | — | — | — |
Pretax income | 2.4B | 3.9B | 5.7B | 4.0B |
Tax provision | 612.1M | 1.1B | 1.5B | 1.0B |
Net income | 1.7B | 2.8B | 4.2B | 2.9B |
Basic EPS | — | 31.3 | 47.0 | 32.6 |
Diluted EPS | — | 30.7 | 46.2 | 32.0 |
Basic average shares | — | 90.1M | 90.1M | 89.9M |
Diluted average shares | — | 91.7M | 91.7M | 91.6M |
EBITDA | 3.4B | 4.9B | 6.7B | 4.8B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |